Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.

Item
http://www.wikidata.org/entity/Q40713473
Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discoveryInvolvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response.Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones.High yield and efficient expression and purification of the human 5-HT3A receptorIndividual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Vortioxetine for the treatment of major depressive disorder.Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.Anti-anxiety effect of a novel 5-HT₃ receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice.The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitroAntidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models.Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats.QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
P2860

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.

Item
http://www.wikidata.org/entity/Q40713473
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Behavioural pharmacology of 5- ...... date on therapeutic potential.
@en
type
label
Behavioural pharmacology of 5- ...... date on therapeutic potential.
@en
prefLabel
Behavioural pharmacology of 5- ...... date on therapeutic potential.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Behavioural pharmacology of 5- ...... date on therapeutic potential.
@en
P2093
P304
P31
P356
10.1016/0165-6147(93)90128-7
P433
P478
P577
P698